CTOs on the Move

Tapinator

www.tapinator.com

 
Tapinator (Ticker: TAPM) is a global developer and publisher of mobile games on the iOS, Google Play, and Amazon platforms. The Company focuses on operating its own titles, publishing properties where it holds substantial ownership positions, and making strategic investments into promising mobile companies. Tapinator’s owned and operated portfolio includes over 55 mobile gaming titles that, collectively, have over 30 million users. A number of these titles have risen to the top of the mobile leaderboard charts and have been featured by the Apple, Google, and Amazon App Stores. Founded in 2013, Tapinator is headquartered in New York, with development ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.tapinator.com
  • 140 West 57th Street; Suite 9C
    New York, NY USA 10019
  • Phone: 914.930.6232

Executives

Name Title Contact Details

Similar Companies

Arrow International (Teleflex Incorporated)

Arrow International (Teleflex Incorporated) is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Arrow International (Teleflex Incorporated) is based in Reading, PA. You can find more information on Arrow International (Teleflex Incorporated) at www.arrowintl.com

National Diagnostics

National Diagnostics is a Charlotte, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vita-Med Labs

Vita-Med Labs is a Mesa, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Advisory Board

The Advisory Board is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NeuroPace

The RNS® System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the world`s first and only medical device that can monitor and respond to brain activity. NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The company`s initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.